|
Type 2 diabetes
Citations 361-370 of 449 total displayed.
|
Past content
(since Jan 2001):
|
- Current Perspectives
Burgeoning Dilemmas in the Management of Diabetes and Cardiovascular Disease: Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
- Burton E. Sobel, Robert Frye, and Katherine M. Detre
Circulation 2003;107:636-642, doi:10.1161/01.CIR.0000048897.03553.E4
[Abstract]
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
- Paul M Ridker, Julie E. Buring, Nancy R. Cook, and Nader Rifai
Circulation 2003;107:391-397; published online before print as doi:10.1161/01.CIR.0000055014.62083.05
[Abstract]
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis
- Sridevi Devaraj, Dan Yan Xu, and Ishwarlal Jialal
Circulation 2003;107:398-404; published online before print as doi:10.1161/01.CIR.0000052617.91920.FD
[Abstract]
[Full text]
- Clinical Investigations and Reports
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study
- Martin K. Rutter, Helen Parise, Emelia J. Benjamin, Daniel Levy, Martin G. Larson, James B. Meigs, Richard W. Nesto, Peter W.F. Wilson, and Ramachandran S. Vasan
Circulation 2003;107:448-454; published online before print as doi:10.1161/01.CIR.0000045671.62860.98
[Abstract]
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
- Paul M Ridker, Julie E. Buring, Nancy R. Cook, and Nader Rifai
Circulation published January 27, 2003, doi:10.1161/01.CIR.0000055014.62083.05
[Abstract]
[Full text]
- Cardiology Patient Pages
Cardiovascular Disease in the Diabetic Patient
- Allison B. Goldfine and Harvey L. Goldfine
Circulation 2003;107:e14-16e, doi:10.1161/01.CIR.0000042764.06760.B9
[Full text]
- Articles
Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes
- Philip S. Mehler, Joseph R. Coll, Raymond Estacio, Anne Esler, Robert W. Schrier, and William R. Hiatt
Circulation published January 20, 2003, doi:10.1161/01.CIR.0000049640.46039.52
[Abstract]
- Articles
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function. Sex-Related Differences in the Framingham Heart Study
- Martin K. Rutter, Helen Parise, Emelia J. Benjamin, Daniel Levy, Martin G. Larson, James B. Meigs, Richard W. Nesto, Peter W.F. Wilson, and Ramachandran S. Vasan
Circulation published January 13, 2003, doi:10.1161/01.CIR.0000045671.62860.98
[Abstract]
- Editorials
Hormone Replacement Therapy and Heart Disease: Replacing Dogma With Data
- David M. Herrington
Circulation 2003;107:2-4, doi:10.1161/01.CIR.0000048891.81129.2D
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis
- Sridevi Devaraj, Dan Yan Xu, and Ishwarlal Jialal
Circulation published January 6, 2003, doi:10.1161/01.CIR.0000052617.91920.FD
[Abstract]
[Full text]
|
|
